A
ABL Bio Inc
KOSDAQ:298380
ABL Bio Inc
KOSDAQ:298380
Price:
24 050 KRW
6.18%
Market Closed
Updated:
Jun 3, 2024
Net Margin
ABL Bio Inc
ABL Bio Inc
34.5%
Current
-608%
Average
-8.5%
Industry
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=34.5%
Net Income
/
36.1B
Revenue
104.8B
Net Margin Across Competitors
| Country | KR |
| Market Cap | 1.1T KRW |
| Net Margin |
34%
|
| Country | US |
| Market Cap | 284.7B USD |
| Net Margin |
11%
|
| Country | US |
| Market Cap | 164.1B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 117.6B USD |
| Net Margin |
39%
|
| Country | US |
| Market Cap | 108B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 135.9B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 80.1B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 54.6B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 32.8B USD |
| Net Margin |
12%
|
| Country | IE |
| Market Cap | 26.6B USD |
| Net Margin |
12%
|
Profitability Report
View the profitability report to see the full profitability analysis for ABL Bio Inc.
See Also
Discover More
What is Net Margin?
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=34.5%
Net Income
/
36.1B
Revenue
104.8B
What is the Net Margin of ABL Bio Inc?
Based on ABL Bio Inc's most recent financial statements, the company has Net Margin of 34.5%.
You don't have any saved screeners yet
